EyePoint Pharmaceuticals
EYPT
EYPT
98 hedge funds and large institutions have $269M invested in EyePoint Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 34 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
2% less capital invested
Capital invested by funds: $275M → $269M (-$5.35M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
70% less call options, than puts
Call options by funds: $3.12M | Put options by funds: $10.3M
Holders
98
Holding in Top 10
1
Calls
$3.12M
Puts
$10.3M
Top Buyers
| 1 | +$11M | |
| 2 | +$4.69M | |
| 3 | +$3.49M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$2.6M |
| 5 |
Millennium Management
New York
|
+$1.93M |
Top Sellers
| 1 | -$7.29M | |
| 2 | -$5.59M | |
| 3 | -$2.7M | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$1.12M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.08M |